Macoin, J.; Lissilaa, R.; Sancheti, P.; Reddy, V.; Back, J.; Wolff, G. Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses. J of Skin 2018, 2, S62.